echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Meng Songdong's team has made new progress in the study of autoimmune disease treatment

    Meng Songdong's team has made new progress in the study of autoimmune disease treatment

    • Last Update: 2022-01-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Autoimmune diseases are a large group of chronic inflammatory diseases, which are mainly characterized by the imbalance and abnormal activation of the immune system, and the reduction or loss of tolerance to self-antigens , resulting in immune damage and pathology of normal tissues and organs in the body .


    Regulatory T cells ( Treg ) are a class of T cell subsets with immunosuppressive and regulatory effects , which can inhibit the activation, proliferation and differentiation of various immune cell subtypes, maintain the body's immune homeostasis and immune resistance to self-antigens.


    Meng Songdong's team from the Institute of Microbiology, Chinese Academy of Sciences has been engaged in the study of the immunological function of heat shock protein gp96 for more than ten years .


    This study clarified the mechanism of gp96 -mediated Treg activation, verified that activated Treg can effectively inhibit autoantibodies and Th cell-induced autoimmune diseases, and provided a basis for the development of drugs for the treatment of autoimmune diseases by activating Treg .


    The mechanism of heat shock protein gp96 activation of Treg 

    The above research results have been published in the journal iScience in December 2021.


    Full text link: https://doi.


     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.